LHCFX Mutual Fund

LHCFX Mutual Fund

NAV$24.57
See how much of LHCFX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing the top 10 of 64 holdings · as of Apr 30, 2026
Top 10 weight
37.55%
LHCFX top 10 holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
LLY
Eli Lilly & Co.Health Care · Pharmaceuticals
8.89%		8.9%775$724.3KHealth CarePharmaceuticals
2—AstraZeneca PLC
4.73%		13.6%2,029$384.9K--
Share changes, sector and industry · Pro
3
GILD
Gilead Sciences
4.25%		17.9%2,647$346.3K
4
JNJ
Johnson & Johnson -
3.19%		21.1%1,129$259.5K
5
NKTR
Nektar Therapeutics
3.17%		24.2%3,038$258.4K
6
NTRA
Natera Inc
2.91%		27.1%1,151$237.3K
7
TARS
Tarsus Pharmaceuticals Inc
2.83%		30.0%3,622$230.4K
8
GH
Guardant Health Inc
2.63%		32.6%2,459$214.1K
9—Argenx Se
2.49%		35.1%259$203.1K
10
NVS
Novartis Ag Ordinary Shares
2.46%		37.6%1,356$200.4K
More holdings · Pro
FundXLS Pro
See the other 54 holdings of LHCFX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime
Themes in the top 10
PharmaceuticalsBiotechnologyImmunologyOncologyMedical DevicesLife Sciences ToolsDigital Health

LHCFX Mutual Fund Top Holdings

LHCFX holdings top 10 positions. The top 10 holdings account for 37.6% of the fund, led by Eli Lilly & Co. at 8.9%, AstraZeneca PLC at 4.7%, Gilead Sciences at 4.3%.

LHCFX portfolio concentration is moderate, with the top 10 representing 37.6% of total assets. The largest sector exposure is Health Care at 80.2%.

LHCFX sectors provide a detailed breakdown. LHCFX overlap shows how holdings compare to other funds in your portfolio.